Highest Yielding ‘Dogs of the Dow’ Could Be Massive Total Return Winners For 2024
The ‘Dogs of the Dow’ is a well-known strategy first published in 1991 by Michael Higgins. The strategy seeks to maximize the yield of investments by buying the ten highest-paying dividend stocks available from the Dow Jones Industrial Average each year. The highest-yielding stocks are also the lowest-priced stocks in the venerable average, as the lower a stock (or bond) goes in price, the higher the attached yield or coupon becomes.
We decided to see how this year’s group is fairing as we have just a month left for 2023. While the stocks in the group have changed since the start of the year, the reality is that they also have become an excellent contrarian idea in a market that is very overbought in an economy that could suffer six months from now.
With the Nasdaq up over 37% and the S&P 500 up 19.2%, investors are trying to play catch-up on the big tech giants that have been driving the market rally and may be trying to pick up nickels in front of a bulldozer as the lion’s share of the big money has been made.
Here are the current five highest-yielding “Dogs of the Dow” listed in order of the highest yield.
Walgreens Boots Alliance
This huge drugstore chain is a safe retail play for investors looking to add health care now and trades at a very cheap 7.5 times 2023 earnings expectations. Walgreens Boots Alliance (NYSE: WBA) is a pharmacy-led health and beauty retail company.
The company operates through three segments:
- Retail Pharmacy USA
- Retail Pharmacy International
- Pharmaceutical Wholesale
The Retail Pharmacy USA segment sells prescription drugs and various retail products, including health, wellness, beauty, personal care, consumables, and general merchandise, through its retail drugstores. It also provides specialty pharmacy and mail services; this segment operates nearly 10,000 retail stores under the Walgreens and Duane Reade brands in the United States and six specialty pharmacies.
The Retail Pharmacy International segment sells prescription drugs, health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,428 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile, and 550 optical practices, including 165 on a franchise basis.
The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers.
This article was originally published on this site